Pays: Suisse
Langue: français
Source: Swissmedic (Swiss Agency for Therapeutic Products)
neostigmini metilsulfas
MEDA Pharmaceuticals Switzerland GmbH
N07AA01
neostigmini metilsulfas
Solution injectable
neostigmini metilsulfas 0.5 mg, natrii chloridum, acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
B
Synthetika
Cholinergicum, Antimyasthenicum
zugelassen
1952-04-25